The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dutasteride Krka 0.5 mg capsules, soft

KRKA, d.d., Novo mestoPA1347/069/001

Main Information

Trade NameDutasteride Krka 0.5 mg capsules, soft
Active SubstancesDutasteride
Dosage FormCapsule, soft
Licence HolderKRKA, d.d., Novo mesto
Licence NumberPA1347/069/001

Group Information

ATC CodeG04CB Testosterone-5-alpha reductase inhibitors
G04CB02 dutasteride


License statusAuthorised
Licence Issued01/03/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0140-040-001
Interchangeable List DocumentPDF of Interchangeable List
« Back